papillary thyroid cancer glp-1 Glucagon-like peptide 1 receptor agonist use and risk of cancer: Scandinavian cohort study Glucagon-like peptide-1 receptor (GLP-1R) expression
Description
Nonalcoholic steatohepatitis (NASH), as a severe form of nonalcoholic fatty liver disease (NAFLD), is characterized by liver steatosis, inflammation, hepatocellular injury and different degrees of fibrosis
A new era for weight loss
In a recent study, researchers found that GLP-1RA medications such as Ozempic and Wegovy are associated with a higher risk of post-endoscopy aspiration pneumonia.
Stopping GLP-1 medications triggers metabolic changes within weeks
